Search - tctmd.com

Displaying 1 - 20 of 486

Sort: Relevancy | Date

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Caitlin E. Cox

August 13, 2025

News Daily News

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

L.A. McKeown

July 30, 2025

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

News Conference News NY Valves 2025

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World

Yael L. Maxwell

June 30, 2025

News Daily News

Tendyne Approved in US for High-risk Patients With Mitral Valve Disease

Michael O'Riordan

May 28, 2025

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

News Daily News

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Caitlin E. Cox

February 14, 2025

News Conference News PCR London Valves 2024

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Michael O'Riordan

December 05, 2024

Presentation TCT 2024

TCT 630: Factors Associated With Readmissions After Mitraclip Procedure: Insights From the National Readmissions Database (NRD)

Presenter: Rohan Umrani

October 27, 2024

Presentation TCT 2024

TCT 626: The Impact of Post-implantation Leaflet Height on Mitral Regurgitation Recurrence After MitraClip for Degenerative Disease

Presenter: Davide Margonato

October 27, 2024

Presentation TCT 2024

Impact of MitraClip on Hospitalization Rates in Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights From RESHAPE-HF2

Presenter: Ralph von Bardeleben

October 27, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2024

Shelley Wood

October 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Shelley Wood

September 01, 2024

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Shelley Wood

August 31, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2024

Shelley Wood

July 31, 2024

News Daily News

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Shelley Wood

July 09, 2024

Advertisement

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World

Tendyne Approved in US for High-risk Patients With Mitral Valve Disease

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

TCT 630: Factors Associated With Readmissions After Mitraclip Procedure: Insights From the National Readmissions Database (NRD)

TCT 626: The Impact of Post-implantation Leaflet Height on Mitral Regurgitation Recurrence After MitraClip for Degenerative Disease

Impact of MitraClip on Hospitalization Rates in Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights From RESHAPE-HF2

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

TCTMD’s Top 10 Most Popular Stories for September 2024

TCTMD’s Top 10 Most Popular Stories for August 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

TCTMD’s Top 10 Most Popular Stories for July 2024

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content